beclomethasone diproprionate
beclomethasone diproprionate
A glucocorticosteroid with enhanced receptor-binding activity, but more rapid presystemic metabolism, which is used in inhalation prophylaxis of asthma, as well as rhinitis and sinusitis.
Pros
Enhanced receptor-binding activity; rapid presystemic metabolism.
Adverse effects
Cough, increased risk of nasopharyngeal candidiasis, dysosmia (smell of burning plastic), dysgeusia, central serous retinopathy.Segen's Medical Dictionary. © 2012 Farlex, Inc. All rights reserved.
beclomethasone diproprionate
Vanceril™ A new steroid molecule with enhanced receptor binding activity, but more rapid presystemic metabolism, which is used as inhalation antiasthmatic therapy. See Asthma. McGraw-Hill Concise Dictionary of Modern Medicine. © 2002 by The McGraw-Hill Companies, Inc.
References in periodicals archive
A randomized trial of intranasal
beclomethasone diproprionate after polypectomy.
The equivalent of 200-500 [micro]g/day of
beclomethasone diproprionate (BDP) would be regarded as a low dose, and the equivalent of 1 000 [micro]g or more of BDP a high dose.
Beclomethasone diproprionate for severe asthma during pregnancy.
(Lake Forest, IL) executed an exclusive option with the University of Texas Medical Branch at Galveston (UTMB) (Galveston, TX) to license patent applications covering the use of oral luminally active anti-inflammatory drugs, such as orBec (oral
beclomethasone diproprionate), for the treatment of irritable bowel syndrome.
Copyright © 2003-2025 Farlex, Inc
Disclaimer
All content on this website, including dictionary, thesaurus, literature, geography, and other reference data is for informational purposes only. This information should not be considered complete, up to date, and is not intended to be used in place of a visit, consultation, or advice of a legal, medical, or any other professional.